Harvard, Tufts med students stage protest at ‘biased’ $2.9B drug development figure

Ben Adams Around two dozen students from Harvard Medical School and Tufts University as well as members of health activist groups protested in front of the Tufts Center for the Study ...

GlaxoSmithKline’s India sales bashed by pricing protest

Carly Helfand Drugmakers weren't exactly thrilled last year when Indian ministers nearly quintupled the list of drugs subject to government price controls. As it turns out, neither ...

Eisai pulls Fycompa in Germany to protest pricing

Tracy Staton Eisai is fed up with Germany's pricing authority. So fed up, in fact, that it plans to stop selling its new seizure drug there. It's just the latest ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS